Harvard's Wyss Institute welcomes MIT as a new collaborating institution

December 04, 2014

(BOSTON) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that MIT has joined the Wyss Institute collaborative consortium. MIT, a world leader in scientific and technological research, becomes the Wyss Institute's 12th collaborating institution, joining Beth Israel Deaconess Medical Center, Boston Children's Hospital, Boston University, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Tufts University, Charité - Universitätsmedizin Berlin, and University of Zurich.

"The Boston-Cambridge technology ecosystem is one of the most dynamic breeding grounds for innovation in the world," said Wyss Institute Founding Director Donald Ingber, Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences. "MIT's participation will allow us to work together to produce disruptive technologies for medicine and the environment, and accelerate their translation into products that will have near-term impact."

The key initial focus will be led by James Collins, Ph.D., a Core Faculty member at the Wyss Institute and a Professor of Biological Engineering at MIT, where he is also a core member of the Institute for Medical Engineering and Science. Collins, who is also Senior Associate Member of the Broad Institute, will work on improving rationality and practicality in the design and application of synthetic biology technologies. Wyss and others at MIT will jointly develop new strategies for biologic drug design, gene therapies, stem cell engineering and development of novel diagnostics using engineered gene circuits, with the goal of moving synthetic biology from the confines of the laboratory to the marketplace.

"This new relationship with the Wyss Institute allows MIT to build on our strengths at the intersection of engineering, science, and clinical medicine," says Arup K. Chakraborty, Director of the Institute for Medical Engineering and Science at MIT. "There is no greater concentration of activity and research on this topic anywhere else in the world. These kinds of collaborations will bring solutions to problems we've never been able to address before."

MIT will gain access to the Wyss Institute's key technology platforms, including Anticipatory Medical and Cellular Devices, Synthetic Biology, Adaptive Material Technologies, Biomimetic Microsystems, Bioinspired Robotics, and Programmable Nanomaterials, as well as the Wyss Institute's unique technology translation model, which takes lead high-value technologies that emerge from Wyss faculty efforts, and de-risks them both technically and commercially to increase their likelihood for real-world translation.
-end-
The Wyss Institute for Biologically Inspired Engineering at Harvard University uses Nature's design principles to develop bioinspired materials and devices that will transform medicine and create a more sustainable world. Working as an alliance among all of Harvard's Schools, and in partnership with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Boston University, Tufts University, and Charité - Universitätsmedizin Berlin, University of Zurich and Massachusetts Institute of Technology, the Institute crosses disciplinary and institutional barriers to engage in high-risk research that leads to transformative technological breakthroughs. By emulating Nature's principles for self-organizing and self-regulating, Wyss researchers are developing innovative new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing. These technologies are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and new start-ups.

Wyss Institute for Biologically Inspired Engineering at Harvard

Related Synthetic Biology Articles from Brightsurf:

Deep learning takes on synthetic biology
Machine learning is helping biologists solve hard problems, including designing effective synthetic biology tools.

Machine learning takes on synthetic biology: algorithms can bioengineer cells for you
Scientists at Lawrence Berkeley National Laboratory have developed a new tool that adapts machine learning algorithms to the needs of synthetic biology to guide development systematically.

Cell-free synthetic biology comes of age
In a review paper published in Nature Reviews Genetics, Professor Michael Jewett explores how cell-free gene expression stands to help the field of synthetic biology dramatically impact society, from the environment to medicine to education.

Scientists develop electrochemical platform for cell-free synthetic biology
Scientists at the University of Toronto (U of T) and Arizona State University (ASU) have developed the first direct gene circuit to electrode interface by combining cell-free synthetic biology with state-of-the-art nanostructured electrodes.

Gene-OFF switches tool up synthetic biology
Wyss researchers and their colloaborators have developed two types of programmable repressor elements that can switch off the production of an output protein in synthetic biology circuits by up to 300-fold in response to almost any triggering nucleotide sequence.

Tennessee researchers join call for responsible development of synthetic biology
Engineering biology is transforming technology and science. Researchers in the international Genome Project-write, including two authors from the UTIA Center for Agricultural Synthetic Biology, outline the technological advances needed to secure a safe, responsible future in the Oct.

Scientists chart course toward a new world of synthetic biology
A UC Berkeley team with NSF funding has compiled a roadmap for the future of synthetic or engineering biology, based on the input of 80 leaders in the field from more than 30 institutions.

DFG presents position paper on synthetic biology
Clear distinction between synthetic biology and underlying methods required / No new potential risks associated with current research work

Commandeering microbes pave way for synthetic biology in military environments
A team of scientists from the US Army Research Laboratory and the Massachusetts Institute of Technology have developed and demonstrated a pioneering synthetic biology tool to deliver DNA programming into a broad range of bacteria.

BioBits: Teaching synthetic biology to K-12 students
As biologists have probed deeper into the genetic underpinnings of life, K-12 schools have struggled to provide a curriculum that reflects those advances.

Read More: Synthetic Biology News and Synthetic Biology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.